首页 > 最新文献

International journal of research in ayurveda and pharmacy最新文献

英文 中文
AYURVEDIC APPROACH TO TREAT CHRONIC RESIDUAL BELL’S PALSY IN CHILDREN: A CASE REPORT 阿育吠陀疗法治疗儿童慢性残余贝尔氏麻痹1例
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140375
A. As, C. Das
Introduction: Bell’s palsy is the most common type of unilateral facial paralysis (60%-75%). The etiopathogenesis of Bell’s palsy is uncertain. The clinical features include acute onset of unilateral facial paralysis, poor eyelid closure, posterior auricular pain, numbness of cheeks, and deviation of the angle of the mouth towards the unaffected side. Bell’s palsy can be understood as Ardita in Ayurveda. Acharya Sushruta has included bala as a susceptible group while describing the vishesha nidanas of Ardita. Aims and Ideas: To study the effect of a framed Ayurvedic treatment protocol in managing chronic residual Bell’s palsy in children. Methods: The present case was a chronic right-sided residual Bell’s palsy with a history of 12 years and was approached through the line of management of Ardita mentioned in Bruhattrayees and Yogamrutam for 12 days. The treatment was started with takra dhara to give mrdu rookshana. Takra dhara mukha abhyanga and ksheera dhoomam were administered, followed by marsha nasyam. Two specific treatments mentioned in Yogamrutam was adopted in this case, i.e., panasa patra swedam and navaneeta shiro talam. The treatment was ended with shashtika shala pinda swedana to mukha. Results and Discussions: The facial asymmetry was reduced by 60% at the end of the treatment. Watering of the right was subsided entirely, and there was complete effortless closure of the right year after treatment. Pain, twitching and numbness on the right half of the face were utterly absent. The House and Brackmann grade was reduced from Grade III to Grade II after 12 days of treatment.
贝尔麻痹是最常见的单侧面瘫类型(60%-75%)。贝尔氏麻痹的发病机制尚不清楚。临床特征包括急性发作的单侧面瘫、闭眼不良、耳后疼痛、面颊麻木、口向未患侧倾斜。贝尔麻痹症可以理解为阿育吠陀中的阿迪塔。《阿查里亚·苏什鲁塔》在描述阿迪塔的毗湿婆尼达纳斯时,将巴拉作为一个易受影响的群体。目的与思路:研究阿育吠陀治疗方案框架在儿童慢性残余贝尔氏麻痹治疗中的效果。方法:本病例为慢性右侧残余贝尔氏麻痹,病史12年,经Bruhattrayees和Yogamrutam中提到的Ardita治疗线治疗12天。治疗开始时,杜·鲁克莎娜服用了陀罗达拉。首先是Takra dhara mukha abhyanga和ksheera dhoomam,然后是marsha nasyam。本案例采用了Yogamrutam中提到的两种具体处理方法,即panasa patra swedam和navaneeta shiro talam。治疗以shashtika shala pinda swedana to mukha结束。结果与讨论:治疗结束时,面部不对称减少了60%。右侧的浇水完全消退,并且在治疗后一年完全轻松关闭右侧。右半边脸完全没有疼痛、抽搐和麻木。治疗12天后,House和Brackmann评分由III级降至II级。
{"title":"AYURVEDIC APPROACH TO TREAT CHRONIC RESIDUAL BELL’S PALSY IN CHILDREN: A CASE REPORT","authors":"A. As, C. Das","doi":"10.7897/2277-4343.140375","DOIUrl":"https://doi.org/10.7897/2277-4343.140375","url":null,"abstract":"Introduction: Bell’s palsy is the most common type of unilateral facial paralysis (60%-75%). The etiopathogenesis of Bell’s palsy is uncertain. The clinical features include acute onset of unilateral facial paralysis, poor eyelid closure, posterior auricular pain, numbness of cheeks, and deviation of the angle of the mouth towards the unaffected side. Bell’s palsy can be understood as Ardita in Ayurveda. Acharya Sushruta has included bala as a susceptible group while describing the vishesha nidanas of Ardita. Aims and Ideas: To study the effect of a framed Ayurvedic treatment protocol in managing chronic residual Bell’s palsy in children. Methods: The present case was a chronic right-sided residual Bell’s palsy with a history of 12 years and was approached through the line of management of Ardita mentioned in Bruhattrayees and Yogamrutam for 12 days. The treatment was started with takra dhara to give mrdu rookshana. Takra dhara mukha abhyanga and ksheera dhoomam were administered, followed by marsha nasyam. Two specific treatments mentioned in Yogamrutam was adopted in this case, i.e., panasa patra swedam and navaneeta shiro talam. The treatment was ended with shashtika shala pinda swedana to mukha. Results and Discussions: The facial asymmetry was reduced by 60% at the end of the treatment. Watering of the right was subsided entirely, and there was complete effortless closure of the right year after treatment. Pain, twitching and numbness on the right half of the face were utterly absent. The House and Brackmann grade was reduced from Grade III to Grade II after 12 days of treatment.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87553783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IMPORTANCE OF RASOUSHADHIS IN AYURVEDA: A REVIEW 在阿育吠陀中的重要性:综述
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140398
Shiwali Sharma, U. Sharma, Shuchi Mitra, K. Sharma
If used wisely, science is a boon to humanity and, if misused, can be hazardous. Ayurveda is one of the primordial systems of medical science that has elaborated the causes and methods of drug-induced consequences and preventive measures. Every system has some flaws, which need to be noted and rectified no matter how excellent the system is. In rasoushadhis (herbomineral formulations) preparation, specific techniques like shodhana, jarana and marana etc., have been developed to prepare more bio-assimilable forms of rasaushadha dravya. The indications, dose, vehicle, period of drug administration, interval or duration of treatment, diagnosis of the disease, nature or prakriti of the patient, pathya-apathya (favourable-unfavourable regimen) etc., are significant factors that the physician should always consider before they recommend these rasoushadhis to the patients. This review compiles the standard procedures which are adopted during the preparation of rasoushadhis like Shodhana, and Marana, the utility of rasoushadhis in Ashtanga Ayurveda, skin diseases, lifestyle disorders etc. and the rational use of rasoushadhis to understand and highlight the importance and uniqueness of rasoushadhis.
如果使用得当,科学是人类的福音,如果滥用,则可能是危险的。阿育吠陀是医学科学的原始系统之一,它阐述了药物引起的后果和预防措施的原因和方法。每一个制度都有缺陷,再优秀的制度都需要注意和纠正。在草药制剂的制备中,已经开发了诸如shodhana、jarana和marana等特定技术,以制备更具生物可吸收形式的rasaushadha dravya。适应症、剂量、载体、给药时间、治疗间隔或持续时间、疾病的诊断、患者的性质或prakriti、pathya-apathya(有利-不利方案)等,是医生在向患者推荐这些rasoushahis之前应始终考虑的重要因素。本综述汇编了rasoushaha(如Shodhana和Marana)制备过程中采用的标准程序,rasoushaha在阿斯汤伽阿育吠陀中的应用,皮肤病,生活方式失调等,以及rasoushaha的合理使用,以了解和突出rasoushaha的重要性和独特性。
{"title":"IMPORTANCE OF RASOUSHADHIS IN AYURVEDA: A REVIEW","authors":"Shiwali Sharma, U. Sharma, Shuchi Mitra, K. Sharma","doi":"10.7897/2277-4343.140398","DOIUrl":"https://doi.org/10.7897/2277-4343.140398","url":null,"abstract":"If used wisely, science is a boon to humanity and, if misused, can be hazardous. Ayurveda is one of the primordial systems of medical science that has elaborated the causes and methods of drug-induced consequences and preventive measures. Every system has some flaws, which need to be noted and rectified no matter how excellent the system is. In rasoushadhis (herbomineral formulations) preparation, specific techniques like shodhana, jarana and marana etc., have been developed to prepare more bio-assimilable forms of rasaushadha dravya. The indications, dose, vehicle, period of drug administration, interval or duration of treatment, diagnosis of the disease, nature or prakriti of the patient, pathya-apathya (favourable-unfavourable regimen) etc., are significant factors that the physician should always consider before they recommend these rasoushadhis to the patients. This review compiles the standard procedures which are adopted during the preparation of rasoushadhis like Shodhana, and Marana, the utility of rasoushadhis in Ashtanga Ayurveda, skin diseases, lifestyle disorders etc. and the rational use of rasoushadhis to understand and highlight the importance and uniqueness of rasoushadhis.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"21 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91547065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFFECT OF UTSADANIYA LEPA IN WOUND BED PREPARATION: A CASE REPORT 乌旦旦草在伤口床准备中的作用1例报告
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140370
Jyoti N. Shinde, Vaishnavi H. Hande, Sandesh Khobragade
Aim: To evaluate the effect of local application of Utsadaniya lepa (Application of herbal paste to a wound-producing granulation) in wound bed preparation. Materials and methods: A surgically created deep wound was managed with the local application of lepa of Utsadaniya dravyas (drugs) mixed with goghruta (ghee). Jalaukavacharana (leech therapy) and vrana dhavana (washing) with Triphala kwatha were also administered as adjuvant medication. Observation: Utsadaniya lepa has an important role in enhancing the process of granulation formation in shuddha vrana. Result: Post debridement deep wound on the dorsum of the right foot was treated successfully with Utsadaniya lepa to achieve wound bed preparation for further surgical intervention, i.e., split skin grafting. Conclusion: Utsadaniya lepa effectively reduces the wound's depth by accelerating the process of granulation formation.
目的:评价中药贴敷创面肉芽在创面制剂中的应用效果。材料和方法:手术创面创面局部应用乌萨达尼亚·德拉维雅(药物)混合goghruta(酥油)处理。Jalaukavacharana(水蛭疗法)和vrana dhavana(冲洗)与Triphala kwatha也给予辅助用药。观察:乌苏丹草对促进首足部肉芽形成过程有重要作用。结果:右脚背深度创面清创后用Utsadaniya lepa成功处理,为后续手术介入即裂皮植皮做好创床准备。结论:乌苏丹草可通过加速肉芽形成的过程有效地减少创面深度。
{"title":"EFFECT OF UTSADANIYA LEPA IN WOUND BED PREPARATION: A CASE REPORT","authors":"Jyoti N. Shinde, Vaishnavi H. Hande, Sandesh Khobragade","doi":"10.7897/2277-4343.140370","DOIUrl":"https://doi.org/10.7897/2277-4343.140370","url":null,"abstract":"Aim: To evaluate the effect of local application of Utsadaniya lepa (Application of herbal paste to a wound-producing granulation) in wound bed preparation. Materials and methods: A surgically created deep wound was managed with the local application of lepa of Utsadaniya dravyas (drugs) mixed with goghruta (ghee). Jalaukavacharana (leech therapy) and vrana dhavana (washing) with Triphala kwatha were also administered as adjuvant medication. Observation: Utsadaniya lepa has an important role in enhancing the process of granulation formation in shuddha vrana. Result: Post debridement deep wound on the dorsum of the right foot was treated successfully with Utsadaniya lepa to achieve wound bed preparation for further surgical intervention, i.e., split skin grafting. Conclusion: Utsadaniya lepa effectively reduces the wound's depth by accelerating the process of granulation formation.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90445025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PILOT STUDY ON EFFECTIVENESS OF SIDDHA MEDICINES SOMBU THEENEER (INTERNAL) AND PEENISATHIRKU THAILAM (EXTERNAL) IN THE MANAGEMENT OF PEENISAM (SINUSITIS) siddha药物sombu theeneer(内服)和peenisatthirku thailand(外服)治疗鼻窦炎疗效的初步研究
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140384
G. Dhivya, H. Kumari, H. Sofia, T. Kantham, R. Kumari
Background: Peenisam (sinusitis) is a widespread condition, and patients are visiting Ayothidass Pandithar Hospital, National Institute of Siddha, to manage this condition. The signs and symptoms of peenisam (sinusitis) are mentioned in Siddha literature Yugi vaithya chinthamani, such as lacrimation, nasal block, headache, rhinorrhea, cough, absence of taste, may be correlated with maxillary sinusitis in biomedicine. Objectives: To evaluate the clinical effectiveness of Siddha formulations Sombu theeneer (internal) and Peenisathirku thailam (external) in the management of sinusitis by using Adelaide Disease Severity Score (ADSS) and to observe changes in clinical lab parameters, total count, differential count, erythrocyte sedimentation rate, absolute eosinophil count and serum immunoglobulin E pre and post-treatment. Methods: An open Non-Randomised clinical trial with a sample size of 10 patients diagnosed with Peenisam within the age limit of 18-60 years. The approval was obtained from Institutional Ethical Committee for conducting this clinical study with the IEC No: (25/11/2021; NIS/IEC/2021/MP-3). It was registered prospectively in the Clinical Trail Registry of India (CTRI Reg No: CTRI/2022/01/051045). The trial drug Sombu theeneer (internal) 30 ml BD with water after food and Peenisathirku thailam (external) were given for 48 days and two months follow up without the trial drug. Results: Biostatistical reports of ADSS scores and lab investigations before and after treatment were statistically analysed using paired t-tests. There was a significant reduction in both the ADSS.
背景:Peenisam(鼻窦炎)是一种广泛存在的疾病,患者到Siddha国家研究所Ayothidass Pandithar医院治疗这种疾病。释迦牟尼文献中提到的鼻窦炎的体征和症状,如流泪、鼻塞、头痛、流涕、咳嗽、味觉缺失等,在生物医学上可能与上颌鼻窦炎有关。目的:采用阿德莱德疾病严重程度评分(ADSS)方法,评价西达方(内服)和泰服(外服)治疗鼻窦炎的临床疗效,观察治疗前后临床实验室参数、总计数、鉴别计数、红细胞沉降率、绝对嗜酸性粒细胞计数和血清免疫球蛋白E的变化。方法:一项开放的非随机临床试验,样本量为10例年龄在18-60岁之间诊断为Peenisam的患者。该临床研究已获得机构伦理委员会的批准,IEC号:(25/11/2021;NIS / IEC / 2021 / mp - 3)。该药物已在印度临床试验注册中心(CTRI注册编号:CTRI/2022/01/051045)进行前瞻性注册。试验性药物松布西尼尔(内服)30 ml BD,餐后加水给药,泰国培尼思库(外服)48天,无试验性药物随访2个月。结果:采用配对t检验对治疗前后ADSS评分和实验室调查的生物统计学报告进行统计学分析。两者的ADSS都有显著降低。
{"title":"PILOT STUDY ON EFFECTIVENESS OF SIDDHA MEDICINES SOMBU THEENEER (INTERNAL) AND PEENISATHIRKU THAILAM (EXTERNAL) IN THE MANAGEMENT OF PEENISAM (SINUSITIS)","authors":"G. Dhivya, H. Kumari, H. Sofia, T. Kantham, R. Kumari","doi":"10.7897/2277-4343.140384","DOIUrl":"https://doi.org/10.7897/2277-4343.140384","url":null,"abstract":"Background: Peenisam (sinusitis) is a widespread condition, and patients are visiting Ayothidass Pandithar Hospital, National Institute of Siddha, to manage this condition. The signs and symptoms of peenisam (sinusitis) are mentioned in Siddha literature Yugi vaithya chinthamani, such as lacrimation, nasal block, headache, rhinorrhea, cough, absence of taste, may be correlated with maxillary sinusitis in biomedicine. Objectives: To evaluate the clinical effectiveness of Siddha formulations Sombu theeneer (internal) and Peenisathirku thailam (external) in the management of sinusitis by using Adelaide Disease Severity Score (ADSS) and to observe changes in clinical lab parameters, total count, differential count, erythrocyte sedimentation rate, absolute eosinophil count and serum immunoglobulin E pre and post-treatment. Methods: An open Non-Randomised clinical trial with a sample size of 10 patients diagnosed with Peenisam within the age limit of 18-60 years. The approval was obtained from Institutional Ethical Committee for conducting this clinical study with the IEC No: (25/11/2021; NIS/IEC/2021/MP-3). It was registered prospectively in the Clinical Trail Registry of India (CTRI Reg No: CTRI/2022/01/051045). The trial drug Sombu theeneer (internal) 30 ml BD with water after food and Peenisathirku thailam (external) were given for 48 days and two months follow up without the trial drug. Results: Biostatistical reports of ADSS scores and lab investigations before and after treatment were statistically analysed using paired t-tests. There was a significant reduction in both the ADSS.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84510569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TREATMENT MODALITIES IN TREATING AMA CONDITIONS WITH SPECIAL REFERENCE TO AUTOIMMUNE DISEASES: A REVIEW 与自身免疫性疾病相关的ama疾病的治疗方法综述
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140389
O. Surekha, A. Swaroopa, P. Babu
The main fundamental concept of Ayurveda is to preserve the health of a healthy person and cure the disease of an unhealthy person, i.e., prevention and cure. Acharya Charaka has enumerated various rasayana at the very beginning of chikitsa sthana, which explains the role of prevention that comes prior to cure in Ayurveda. In autoimmunity and their diseases, where the cause is unknown, a person's immune system reacts to self-proteins causing various inflammations, fevers, etc., destroying body tissues and changes in organ functioning, leading to more significant morbidities over time. While treating these conditions, the primary objective of a physician should be relieving the patient’s symptoms and correcting the imbalance created in his immune system without further compromising it. Here comes Ayurveda, the ancient holistic science of life, where acharyas have provided various formulations, purificatory mechanisms, and rejuvenator elixirs in treating such exasperating diseases with the concept called “Ama” by correcting the agni the Élan vital of life. The imperfectly digested anna rasa due to impaired agni is known as ama. The present article lists all possible treatments for treating sama conditions with special reference to autoimmune diseases.
阿育吠陀的主要基本概念是保持健康人的健康,治愈不健康人的疾病,即预防和治疗。阿查里亚·查罗卡在奇奇萨纳的一开始就列举了各种各样的拉萨那,这解释了阿育吠陀中预防先于治疗的作用。在病因不明的自身免疫及其疾病中,一个人的免疫系统对自身蛋白质作出反应,引起各种炎症、发烧等,破坏身体组织,改变器官功能,随着时间的推移,导致更严重的发病率。在治疗这些疾病时,医生的主要目标应该是减轻病人的症状,纠正免疫系统的失衡,而不是进一步损害它。阿育吠陀(Ayurveda)是一门古老的整体生命科学,阿查里亚(acharya)提供了各种配方、净化机制和恢复活力的灵丹妙药,通过纠正生命至关重要的火气Élan,以“阿玛”(Ama)的概念治疗这些令人恼火的疾病。由于agni受损而无法完全消化的anna rasa被称为ama。本文列出了所有可能的治疗sama疾病的方法,特别是自身免疫性疾病。
{"title":"TREATMENT MODALITIES IN TREATING AMA CONDITIONS WITH SPECIAL REFERENCE TO AUTOIMMUNE DISEASES: A REVIEW","authors":"O. Surekha, A. Swaroopa, P. Babu","doi":"10.7897/2277-4343.140389","DOIUrl":"https://doi.org/10.7897/2277-4343.140389","url":null,"abstract":"The main fundamental concept of Ayurveda is to preserve the health of a healthy person and cure the disease of an unhealthy person, i.e., prevention and cure. Acharya Charaka has enumerated various rasayana at the very beginning of chikitsa sthana, which explains the role of prevention that comes prior to cure in Ayurveda. In autoimmunity and their diseases, where the cause is unknown, a person's immune system reacts to self-proteins causing various inflammations, fevers, etc., destroying body tissues and changes in organ functioning, leading to more significant morbidities over time. While treating these conditions, the primary objective of a physician should be relieving the patient’s symptoms and correcting the imbalance created in his immune system without further compromising it. Here comes Ayurveda, the ancient holistic science of life, where acharyas have provided various formulations, purificatory mechanisms, and rejuvenator elixirs in treating such exasperating diseases with the concept called “Ama” by correcting the agni the Élan vital of life. The imperfectly digested anna rasa due to impaired agni is known as ama. The present article lists all possible treatments for treating sama conditions with special reference to autoimmune diseases.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87970949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AYURVEDIC DRUGS IN MANAGEMENT AND UPAKARMA OF VATAJA HRIDROGA: A REVIEW 阿育吠陀药物治疗和治疗痔病:综述
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140394
Sanjana Yadav, Sejal Mhatre, Shrutika Dongre, Vaibhav Maheshwari, Reshma Pore
Hridroga is the most critical ailment described in Ayurveda. Vataja (cardiovascular disorder) is a form of Hridroga that can be distinguished by pathological symptoms described in Ayurveda. It manifests as ruja in urah pradesha (chest discomfort) and other signs and symptoms such as alpanidrata, shvasavrodha, darah, hrutdrava, stambha, stabadha, akasmat deenata, shoka, bhaya, shabdasehsnuta, shunyata, vepathu, and vestana. Ayurveda has a deficit in assessing disease symptoms using standard parameters. In order to diagnose a disease, it is necessary to do an assessment. Vataj Hridroga symptoms include hritshunya bhava, hrit-shosha, bheda and stambha, and moha-murccha. It is primarily due to Vata vitiation. Shaman chikitsa is the most effective treatment for Vataj Hridroga. Classical literature on Vataj Hridroga and Haritakyadi ghritapaan from Charaka Samhita was studied as a source of information. The drugs used to make Haritakyadi ghrita from Bhavaprakasa Nighantu. The literature mentions observations on nidana, samprapti, Vataj Hridroga's rupa, Haritakyadi ghritapaan, and drugs.
痔疮是阿育吠陀所描述的最严重的疾病。Vataja(心血管疾病)是一种Hridroga的形式,可以通过阿育吠陀中描述的病理症状来区分。它表现为胸部不适,以及其他体征和症状,如alpanidrata、shvasavrodha、darah、hrutdrava、stambha、stabadha、akasmat deenata、shoka、bhaya、shabdasehsnuta、shunyata、vepathu和vestana。阿育吠陀在使用标准参数评估疾病症状方面存在缺陷。为了诊断疾病,有必要做一个评估。Vataj Hridroga的症状包括hritshunya bhava, hritt -shosha, bheda和stambha以及moha-murccha。这主要是由于Vata腐蚀。萨满奇奇萨是治疗瓦塔吉的最有效的方法。来自《查拉卡·萨姆塔》(Charaka Samhita)的关于Vataj Hridroga和Haritakyadi ghritapan的经典文献被作为信息来源进行研究。从Bhavaprakasa Nighantu制作Haritakyadi ghrita所用的药物。文献提到了对涅达纳、samprapti、Vataj Hridroga的rupa、Haritakyadi ghritapan和药物的观察。
{"title":"AYURVEDIC DRUGS IN MANAGEMENT AND UPAKARMA OF VATAJA HRIDROGA: A REVIEW","authors":"Sanjana Yadav, Sejal Mhatre, Shrutika Dongre, Vaibhav Maheshwari, Reshma Pore","doi":"10.7897/2277-4343.140394","DOIUrl":"https://doi.org/10.7897/2277-4343.140394","url":null,"abstract":"Hridroga is the most critical ailment described in Ayurveda. Vataja (cardiovascular disorder) is a form of Hridroga that can be distinguished by pathological symptoms described in Ayurveda. It manifests as ruja in urah pradesha (chest discomfort) and other signs and symptoms such as alpanidrata, shvasavrodha, darah, hrutdrava, stambha, stabadha, akasmat deenata, shoka, bhaya, shabdasehsnuta, shunyata, vepathu, and vestana. Ayurveda has a deficit in assessing disease symptoms using standard parameters. In order to diagnose a disease, it is necessary to do an assessment. Vataj Hridroga symptoms include hritshunya bhava, hrit-shosha, bheda and stambha, and moha-murccha. It is primarily due to Vata vitiation. Shaman chikitsa is the most effective treatment for Vataj Hridroga. Classical literature on Vataj Hridroga and Haritakyadi ghritapaan from Charaka Samhita was studied as a source of information. The drugs used to make Haritakyadi ghrita from Bhavaprakasa Nighantu. The literature mentions observations on nidana, samprapti, Vataj Hridroga's rupa, Haritakyadi ghritapaan, and drugs.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86900091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
USE OF APAMARGA KSHARSUTRA IN THE MANAGEMENT OF WART (CHARMAKEELA): A CASE STUDY 在治疗疣(charmakeela)中的应用:一个案例研究
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140371
B. Gadve, Kiran D. Wagh
Introduction: Warts, also known as Verrucae, is a common dermatological condition caused by Human Papilloma Virus (HPV). A wart is generally a small, rough growth typically on human hands or feet but often in other locations that can resemble a cauliflower or a solid blister. According to Ayurveda, this ailment can be compared with Charmakeela, one of the kshudrarogas. Case presentation: A 65-year-old male patient visited OPD complaining of pedunculated growth over the left thigh region, occasionally feeling itching and discomfort at the growth site. Routine blood and urine examination were done and found within normal range. Diagnosis and management: Based on clinical features, the case was diagnosed as a wart (Charmakeela) and suggested for a Ksharasutra ligation procedure on an OPD basis. Treatment aims to destruct hyperkeratotic overgrown skin and to avoid recurrence. Outcome: There was marked improvement in the wart after Ksharasutra ligation; gradually, the wart detached from its base, leaving a minimal scar. Discussion: Satisfactory results were obtained. This case highlights that Ksharasutra ligation is a very effective and invasive procedure and one of the potential treatments for managing warts.
简介:疣,也称为疣,是由人类乳头状瘤病毒(HPV)引起的一种常见皮肤病。疣通常是一种小而粗糙的生长物,通常在人的手或脚上,但通常在其他地方,类似于花椰菜或固体水泡。根据阿育吠陀的说法,这种疾病可以与kshudrarogas之一的Charmakeela相提并论。病例介绍:一名65岁男性患者就诊于OPD,主诉左侧大腿区域有带蒂生长,偶尔感到生长部位瘙痒和不适。血、尿常规检查正常。诊断和处理:根据临床特征,该病例被诊断为疣(Charmakeela),并建议在OPD的基础上进行Ksharasutra结扎手术。治疗的目的是破坏角化过度生长的皮肤,避免复发。结果:喀喇苏陀结扎后疣体明显改善;慢慢地,疣从基部脱落,留下一个极小的疤痕。讨论:取得了满意的效果。这个案例强调了Ksharasutra结扎术是一种非常有效的侵入性手术,也是治疗疣的潜在治疗方法之一。
{"title":"USE OF APAMARGA KSHARSUTRA IN THE MANAGEMENT OF WART (CHARMAKEELA): A CASE STUDY","authors":"B. Gadve, Kiran D. Wagh","doi":"10.7897/2277-4343.140371","DOIUrl":"https://doi.org/10.7897/2277-4343.140371","url":null,"abstract":"Introduction: Warts, also known as Verrucae, is a common dermatological condition caused by Human Papilloma Virus (HPV). A wart is generally a small, rough growth typically on human hands or feet but often in other locations that can resemble a cauliflower or a solid blister. According to Ayurveda, this ailment can be compared with Charmakeela, one of the kshudrarogas. Case presentation: A 65-year-old male patient visited OPD complaining of pedunculated growth over the left thigh region, occasionally feeling itching and discomfort at the growth site. Routine blood and urine examination were done and found within normal range. Diagnosis and management: Based on clinical features, the case was diagnosed as a wart (Charmakeela) and suggested for a Ksharasutra ligation procedure on an OPD basis. Treatment aims to destruct hyperkeratotic overgrown skin and to avoid recurrence. Outcome: There was marked improvement in the wart after Ksharasutra ligation; gradually, the wart detached from its base, leaving a minimal scar. Discussion: Satisfactory results were obtained. This case highlights that Ksharasutra ligation is a very effective and invasive procedure and one of the potential treatments for managing warts.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"44 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83161852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EVALUATION OF COMBINED EFFECT ON ANTIHYPERLIPIDAEMIC ACTIVITY OF MADHUCA LONGIFOLIA AND BUTEA MONOSPERMA L. IN TRITON WR-1339 INDUCED HYPERLIPIDAEMIC RATS 长叶麻和单精子丁茶对triton wr-1339诱导的高脂血症大鼠的联合降脂作用评价
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140383
A. Shrirao, M. M. Rahman, PD Mahure, N. Kochar, A. Chandewar
The use of herbal remedies in India has a long history for various medical conditions. High serum total cholesterol, low-density lipoprotein (LDL) concentrations, and a decline in high-density lipoprotein are the main risk factors for coronary heart disease. It has been observed that Butea monosperma L. flower extract and Madhuca longifolia bark extract have been used traditionally to treat hyperglycaemia and related hyperlipidaemia. The evolution of atherosclerotic plaques and coronary artery disease are known to be accelerated by hyperlipidaemia. In the current study, hyperlipidaemic rats were used as a model to examine the potential antihyperlipidemic effects of a hydroalcoholic extract of Butea monosperma L. flowers (HA-BM) and Madhuca longifolia bark (HA-ML). Triton WR 1339 (400 mg/kg) was administered intraperitoneally (i.p.) once to rats to cause hyperlipidaemia, which resulted in rats with persistently high serum levels of triglycerides and cholesterol. The combined dose of HA-BM (200, 400 and 600 mg/kg/day) and HA-ML (250, 500 and 750 mg/kg/day) at a ratio of 1:1 was given to normal and hyperlipidaemic rats. Serum and liver tissue were analysed for lipid profile, and the activity was compared to the cholesterol-lowering drug, atorvastatin (10 mg/kg). From the above study, it could be concluded that a combined dose of an extract of Butea monosperma L. and Madhuca longifolia not only resulted in a significant reduction in cholesterol, triglyceride, LDL, VLDL level but also increased the HDL level, which is good for health.
在印度,使用草药治疗各种疾病有着悠久的历史。高血清总胆固醇、低密度脂蛋白(LDL)浓度和高密度脂蛋白下降是冠心病的主要危险因素。单精子Butea monosperma L.花提取物和Madhuca longifolia树皮提取物传统上用于治疗高血糖和相关的高脂血症。已知高脂血症可加速动脉粥样硬化斑块和冠状动脉疾病的发展。本研究以高脂血症大鼠为实验对象,研究了单精子丁茶花(HA-BM)和长叶树皮(HA-ML)水醇提取物的潜在降血脂作用。Triton WR 1339 (400 mg/kg)腹腔注射1次,引起大鼠高脂血症,导致大鼠血清甘油三酯和胆固醇水平持续升高。将HA-BM(200、400和600 mg/kg/d)和HA-ML(250、500和750 mg/kg/d)按1:1的比例联合给予正常和高脂血症大鼠。分析血清和肝组织的脂质谱,并与降胆固醇药物阿托伐他汀(10 mg/kg)的活性进行比较。综上所述,单精子Butea monosperma L.和Madhuca longifolia提取物联合使用,不仅可以显著降低胆固醇、甘油三酯、LDL、VLDL水平,还可以提高HDL水平,对健康有益。
{"title":"EVALUATION OF COMBINED EFFECT ON ANTIHYPERLIPIDAEMIC ACTIVITY OF MADHUCA LONGIFOLIA AND BUTEA MONOSPERMA L. IN TRITON WR-1339 INDUCED HYPERLIPIDAEMIC RATS","authors":"A. Shrirao, M. M. Rahman, PD Mahure, N. Kochar, A. Chandewar","doi":"10.7897/2277-4343.140383","DOIUrl":"https://doi.org/10.7897/2277-4343.140383","url":null,"abstract":"The use of herbal remedies in India has a long history for various medical conditions. High serum total cholesterol, low-density lipoprotein (LDL) concentrations, and a decline in high-density lipoprotein are the main risk factors for coronary heart disease. It has been observed that Butea monosperma L. flower extract and Madhuca longifolia bark extract have been used traditionally to treat hyperglycaemia and related hyperlipidaemia. The evolution of atherosclerotic plaques and coronary artery disease are known to be accelerated by hyperlipidaemia. In the current study, hyperlipidaemic rats were used as a model to examine the potential antihyperlipidemic effects of a hydroalcoholic extract of Butea monosperma L. flowers (HA-BM) and Madhuca longifolia bark (HA-ML). Triton WR 1339 (400 mg/kg) was administered intraperitoneally (i.p.) once to rats to cause hyperlipidaemia, which resulted in rats with persistently high serum levels of triglycerides and cholesterol. The combined dose of HA-BM (200, 400 and 600 mg/kg/day) and HA-ML (250, 500 and 750 mg/kg/day) at a ratio of 1:1 was given to normal and hyperlipidaemic rats. Serum and liver tissue were analysed for lipid profile, and the activity was compared to the cholesterol-lowering drug, atorvastatin (10 mg/kg). From the above study, it could be concluded that a combined dose of an extract of Butea monosperma L. and Madhuca longifolia not only resulted in a significant reduction in cholesterol, triglyceride, LDL, VLDL level but also increased the HDL level, which is good for health.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73675217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PHYSIOLOGICAL ASPECT OF TWACHA VARNA: A REVIEW 瓦尔纳瓦查的生理学研究进展
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140391
Suwarna D Vyas, Deepak M Vyas, Pragati P Waghmare, . .
Now a day, Ayurveda is gaining wide popularity in the field of cosmetology. Many cosmetic products are prepared and used on the Ayurvedic concepts. Twacha is matruj bhava. The foetus gets varna in the sixth month of intrauterine life. The word "varna" means lustre of the body. Varna is not just colour but includes all the parameters of healthy and radiant skin. Twacha varna varies among different individuals. In Ayurveda twacha varna occurs as per prakriti. According to current medical science, skin colour depends on the amount of melanin and other factors. So here is an attempt to enlist all the factors responsible for varnotpatti.
如今,阿育吠陀在美容领域越来越受欢迎。许多化妆品都是根据阿育吠陀的概念制备和使用的。Twacha是matruj bhava。胎儿在宫内生命的第六个月就会得到瓦尔纳。“瓦尔纳”这个词的意思是身体的光泽。瓦尔纳不仅仅是颜色,还包括健康和容光焕发的皮肤的所有参数。特瓦查瓦尔纳在不同的个体中有所不同。在阿育吠陀中,twacha varna按照prakriti发生。根据目前的医学科学,皮肤的颜色取决于黑色素的数量和其他因素。因此,这里试图列出所有导致varnotpatti的因素。
{"title":"PHYSIOLOGICAL ASPECT OF TWACHA VARNA: A REVIEW","authors":"Suwarna D Vyas, Deepak M Vyas, Pragati P Waghmare, . .","doi":"10.7897/2277-4343.140391","DOIUrl":"https://doi.org/10.7897/2277-4343.140391","url":null,"abstract":"Now a day, Ayurveda is gaining wide popularity in the field of cosmetology. Many cosmetic products are prepared and used on the Ayurvedic concepts. Twacha is matruj bhava. The foetus gets varna in the sixth month of intrauterine life. The word \"varna\" means lustre of the body. Varna is not just colour but includes all the parameters of healthy and radiant skin. Twacha varna varies among different individuals. In Ayurveda twacha varna occurs as per prakriti. According to current medical science, skin colour depends on the amount of melanin and other factors. So here is an attempt to enlist all the factors responsible for varnotpatti.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"88 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75389300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A REVIEW ON PALITYA AND DHATRYADI RASAYANA 对清静和禅坐的回顾
Pub Date : 2023-06-30 DOI: 10.7897/2277-4343.140390
S. Padma Rani, U. Sharma, Sanjay Singh, K. Sharma
Hair is a valuable anatomical structure of the body, having cosmetological and sociological importance in drafting the beauty and personality of an individual. Greying of hair represents the sign of ageing known as Palitya in Ayurveda. But when hair starts greying before the usual age of onset, known as premature greying of hair. Premature hair greying is called Akalaja Palitya, which occurs due to various factors resulting in the vitiation of Pitta dosha. Due to mankind’s hectic, sedentary and busy schedule, the current scenario is witnessing several challenges, and premature greying of hair is one among them. Premature hair greying has multifactorial aetiology, including oxidative stress, nutritional deficiency, smoking, and dysfunctional thyroid hormones, but the exact aetiology is still unknown. Acharyas have mentioned various rasayana for preventing and treating premature hair greying, i.e., Akalaja Palitya. Rasayana therapy aims primarily to promote the strength and vitality of the body. It also helps maintain the integrity of sapta dhatus (fundamental structural component) by improving digestive power resulting in the sound production of successive dhatus and their malas. Dhatryadi rasayana is a polyherbal formulation consisting of three ingredients, i.e., Dhatri (Emblica officinalis Gaertn.), Bhringraj (Eclipta alba Hassk.) and Tila (Sesamum indicum Linn.). All three plants have the keshya property. Emblica officinalis Gaertn. and Sesamum indicum Linn. both act as a 5α-reductase inhibitor. Eclipta alba Hassk. stimulates the proliferation of follicular keratinocytes by downregulating the TGF-β1 (Transforming Growth Factor Beta 1) expression. Furthermore, all ingredients of Dhatryadi rasayana have antioxidant properties and contribute to essential nutritional supplements required for proper hair development and growth.
头发是一种有价值的身体解剖结构,在塑造一个人的美丽和个性方面具有美容和社会学的重要性。头发变白代表着衰老的迹象,在阿育吠陀中被称为白头病。但是当头发在正常年龄之前开始变白时,被称为头发过早变白。过早的头发变白被称为Akalaja Palitya,这是由于各种因素导致皮塔多莎的破坏而发生的。由于人类忙碌、久坐和繁忙的日程安排,目前的情况见证了几个挑战,过早变白就是其中之一。头发过早变白有多因素的病因,包括氧化应激、营养缺乏、吸烟和甲状腺激素功能失调,但确切的病因尚不清楚。阿查里亚们已经提到了各种预防和治疗过早头发变白的拉萨那,即阿卡拉雅帕利提亚。拉萨那疗法的主要目的是促进身体的力量和活力。它还通过提高消化能力,从而使连续的鱼丸和鱼丸产生良好的效果,帮助维持鱼丸(基本结构成分)的完整性。Dhatryadi rasayana是一种多草药配方,由三种成分组成,即Dhatri (Emblica officinalis Gaertn.), Bhringraj (Eclipta alba Hassk.)和Tila (Sesamum indicum Linn.)。这三种植物都有keshya属性。政府官员们都很高兴。芝麻和芝麻。两者都是5α-还原酶抑制剂。Eclipta alba hask。通过下调TGF-β1(转化生长因子β1)的表达刺激滤泡角质形成细胞的增殖。此外,梵天的所有成分都具有抗氧化特性,并有助于头发正常发育和生长所需的必要营养补充。
{"title":"A REVIEW ON PALITYA AND DHATRYADI RASAYANA","authors":"S. Padma Rani, U. Sharma, Sanjay Singh, K. Sharma","doi":"10.7897/2277-4343.140390","DOIUrl":"https://doi.org/10.7897/2277-4343.140390","url":null,"abstract":"Hair is a valuable anatomical structure of the body, having cosmetological and sociological importance in drafting the beauty and personality of an individual. Greying of hair represents the sign of ageing known as Palitya in Ayurveda. But when hair starts greying before the usual age of onset, known as premature greying of hair. Premature hair greying is called Akalaja Palitya, which occurs due to various factors resulting in the vitiation of Pitta dosha. Due to mankind’s hectic, sedentary and busy schedule, the current scenario is witnessing several challenges, and premature greying of hair is one among them. Premature hair greying has multifactorial aetiology, including oxidative stress, nutritional deficiency, smoking, and dysfunctional thyroid hormones, but the exact aetiology is still unknown. Acharyas have mentioned various rasayana for preventing and treating premature hair greying, i.e., Akalaja Palitya. Rasayana therapy aims primarily to promote the strength and vitality of the body. It also helps maintain the integrity of sapta dhatus (fundamental structural component) by improving digestive power resulting in the sound production of successive dhatus and their malas. Dhatryadi rasayana is a polyherbal formulation consisting of three ingredients, i.e., Dhatri (Emblica officinalis Gaertn.), Bhringraj (Eclipta alba Hassk.) and Tila (Sesamum indicum Linn.). All three plants have the keshya property. Emblica officinalis Gaertn. and Sesamum indicum Linn. both act as a 5α-reductase inhibitor. Eclipta alba Hassk. stimulates the proliferation of follicular keratinocytes by downregulating the TGF-β1 (Transforming Growth Factor Beta 1) expression. Furthermore, all ingredients of Dhatryadi rasayana have antioxidant properties and contribute to essential nutritional supplements required for proper hair development and growth.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"110 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89327818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of research in ayurveda and pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1